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Putrescine-stimulated Intracellular Ca2+ Release for Invasiveness of Rat Ascites 
Hepatoma Cells
Yoshiyuki Ashida,1 Akemichi Ueno, Yoshihiro Miwa, Keiko Miyoshi and Hideo Inoue2
Department of Biochemistry, School of Dentistry, Tokushima University, 3 Kuramoto-cho, Tokushima 770
Our previous study showed that treatment of highly invasive rat ascites hepatoma (LC-AH) cells
with α-difluoromethylornithine (DFMO), an inhibitor of ornithine decarboxylase, decreased both
their intracellular level of putrescine and their in vitro invasion of a monolayer of calf pulmonary
arterial endothelial (CPAE) cells, and that both these decreases were completely reversed by exoge-
nous putrescine, but not spermidine or spermine.  Here we show that all adhering control (DFMO-
untreated) cells migrated beneath CPAE monolayer with morphological change from round to cauli-
flower-shaped cells (migratory cells).  DFMO treatment increased the number of cells that remained
round without migration (nonmigratory cells).  Exogenous putrescine, but not spermidine or sper-
mine, induced transformation of all nonmigratory cells to migratory cells with a concomitant
increase in their intracellular Ca2+ level, [Ca2+]i.  The putrescine-induced increase in their [Ca
2+]i pre-
ceded their transformation and these effects of putrescine were not affected by antagonists of the
voltage-gated Ca2+ channel, but were completely suppressed by ryanodine, which also suppressed the
invasiveness of the control cells.  The DFMO-induced decreases in both [Ca2+]i and the invasiveness
of the cells were restored by thapsigargin, which elevated [Ca2+]i by inhibiting endoplasmic Ca
2+-
ATPase, indicating that thapsigargin mimics the effects of putrescine.  These results support the idea
that putrescine is a cofactor for Ca2+ release through the Ca2+ channel in the endoplasmic reticulum
that is inhibited by ryanodine, this release being initiated by cell adhesion and being a prerequisite
for tumor cell invasion.
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The polyamines spermidine and spermine, and the di-
amine putrescine, as well as normal constituents of all ani-
mal cells.  On the basis of their metabolism under various
physiological conditions as well as the effects of specific
inhibitors of polyamine biosynthesis, polyamines have
been suggested to be important in various cellular func-
tions such as proliferation, differentiation,1–4) cytoskeleton
construction,5) membrane transport6, 7) and receptor res-
ponses.8, 9) However, their physiological roles are not yet
well defined at the molecular level.
We previously reported that pretreatment of a highly in-
vasive tumor cell line, LC-AH cells, with DFMO, a spe-
cific irreversible inhibitor of ornithine decarboxylase (EC
4.1.1.17), decreased both their intracellular level of pu-
trescine and their invasion beneath a CPAE cell monolayer,
without change in their viability, proliferative activity or
levels of spermidine and spermine.10)  We also showed that
these DFMO-induced decreases were completely reversed
by putrescine added to the culture medium during pretreat-
ment with DFMO or during invasion assay in which LC-
AH cells were co-cultured with a CPAE cell layer for 24 h.
Moreover, these reverses were observed only with pu-
trescine, not with 1,3-diaminopropane, spermidine or sper-
mine.10)
The LC-AH cells used in these studies have a very high
cellular putrescine level (73 nmol/mg DNA) which is simi-
lar to their spermidine level (70 nmol/mg DNA).10) This
high putrescine level is a characteristic of these highly
invasive LC-AH cells, the putrescine levels in a variety of
other tumor cells such as Ehrlich ascites,11) B16 mela-
noma,12) Lewis lung carcinoma,13) and leukemia14) cells being
less than 30% of their spermidine levels.  Pretreatment with
0.5 mM DFMO for 5 h induced a 64% decrease in their
putrescine level without significant changes in their intra-
cellular levels of spermidine and spermine.10)  Although 0.5
mM DFMO completely inhibited the ornithine decarbox-
ylase activity of LC-AH cells for more than 24 h, the pres-
ence of 0.5 mM DFMO during invasion assay did not
furhter reduce either their putrescine level or invasiveness,
but significantly decreased their spermidine level (48 nmol/
mg DNA) without change in their spermine level (our
unpublished data).  This finding suggests formation of
putrescine from spermidine through oxidation of acetyl-
spermidine, as has been observed in a variety of animal
tissues and cultured cells,15) including isoproterenol-
stimulated mouse parotid gland,16) calcitriol-activated chick
duodenum,17) rat brain,18) and human melanoma cells.19)  In
the former two in vivo studies, marked increases in tissue
putrescine levels with concomitant decreases in spermidine
levels were observed after injections of the hormones.
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These high cellular levels of putrescine and back-conver-
sion of spermidine to putrescine, which is followed by
induction of ornithine decarboxylase,16, 17) imply that
putrescine is involved in cellular events besides being a
precursor of spermidine.  However, its exact function is
unknown.
In this paper, we investigated the role of putrescine in the
invasiveness of LC-AH cells, and showed that it partici-
pates in elevation of [Ca2+]i through a ryanodine receptor
located in the endoplasmic reticulum.
MATERIALS AND METHODS
Materials  Indo 1-AM was purchased from Dojindo Lab-
oratories (Kumamoto). Ionomycin, A23187, verapamil,
nifedipine, diltiazem, ryanodine and thapsigargin were
obtained from Wako Pure Chemical Industries (Osaka).
The sources of other chemicals, and LC-AH and CPAE
cells were as reported previously.10)
Cell culture and assay of cell invasiveness   These assays
were done as reported previously.10)  Briefly, LC-AH and
CPAE cells were cultured at 37°C in a CO2 incubator in
DMEM supplemented with NaHCO3, antibiotics and 10%
(LC-AH cells) or 20% (CPAE cells) FCS.  For treatment of
LC-AH cells with DFMO, the cells (1.0×106 cells/ml) were
cultured in 10% FCS-DMEM containing 0.5 mM DFMO
for 5 h and then washed with fresh medium to remove
DFMO.  Volumes of 1 ml of LC-AH cell suspension (2×104
cells) were seeded onto confluent CPAE cell monolayers
grown on 12-well plates (3.8 cm2).  After co-culture for 24
h (migration period) in the absence or presence of
putrescine or test drugs, cells were fixed with 10% forma-
lin, and the numbers of tumor cells that had penetrated the
CPAE cell layers were counted under a phase-contrast
microscope.
Assay of cell adhesiveness   The adhesion of the tumor
cells to the CPAE cell layer was determined as follows.
LC-AH cells (1×105 cells) suspended in 4 ml of 10% FCS-
DMEM were seeded onto confluent CPAE cell layers in 60
mm dishes.  After co-culture for 0.5–6 h, the culture me-
dium was removed and the CPAE cell layers were gently
washed with 4 ml of fresh DMEM.  The numbers of nonad-
hered cells in the combined media were counted under a
microscope and the CPAE cell layers were cultured further
for 24 h in 4 ml of 10% FCS-DMEM to assay the invasive-
ness of LC-AH cells that had adhered to the CPAE cell
layers.  Cell adhesion was calculated by subtracting the
number of nonadhered cells from the number of cells
seeded (1×105 cells).
Assay of cell membrane fluidity   Membrane fluidity was
assessed by fluorescence polarization as reported previ-
ously.20)  LC-AH cells treated without or with drug for 5 h
were washed twice with PBS, suspended at a concentration
of 1×105 cells/ml in PBS containing 1.5 µM 1,6-diphenyl-
1,3,5-hexatriene as a fluorescence probe and incubated for
2 h at 37°C.  Fluorescence intensity was measured at 37°C
in a Hitachi fluorescence spectrophotometer equipped with
a polarization accessory.
Morphological observation  Cell morphology was exam-
ined by a slight modification of the method of Akedo et
al.21)  LC-AH cells adhered to a CPAE cell layer were fixed
with 3% glutaraldehyde in 0.1 M cacodylate buffer (pH
7.2) for 1 h and then treated with 1% OsO4 for 2 h.  After
dehydration with ethanol, the samples were dried in a crit-
ical point drier (Hitachi HCP-2), coated with gold and
observed under a Hitachi H-800 scanning electron micro-
scope.  For light microscopic observations, the dehydrated
samples were embedded in Epon 812, sectioned perpendic-
ularly and stained with 1% methylene blue in 1% sodium
borate.
Measurement of [Ca2+]i   The [Ca
2+]i of LC-AH cells was
measured by a modification of the fluorescence method of
Luckhoff.22)  Briefly, control or DFMO-treated LC-AH
cells were incubated for 30 min at 37°C in Hanks’ balanced
salt solution containing 2 µM indo 1-AM.  Then they were
washed twice with the same salt solution, and suspended in
10% FCS-MEM and samples of 1 ml of the cells (2×104
cells) were seeded onto confluent CPAE cells grown in 35
mm culture dishes with a glass bottom (Meridian Instru-
ments, Inc., Okemos, MI).  After co-culture for 2 h, the me-
dium was carefully replaced by Hanks’ balanced salt
solution and the fluorescence intensity and video image of
the LC-AH cells adhering to the CPAE cell layers were
monitored simultaneously for 10 min with an ACAS 570
interactive laser cytometer (Meridian Instruments, Inc.).
Longer monitoring was not possible for technical reasons.
For measurement of [Ca2+]i in LC-AH cells that had pene-
trated the CPAE cell layer, indo 1-AM was loaded into the
co-cultured cells 24 h after inoculation of LC-AH cells and
the fluorescence intensity in the tumor cells was measured
as described above.
The results in figures are shown as typical traces of re-
sults in at least three separate experiments.
Polyamine determination   DFMO-treated cells (1×106
cells) were suspended in 1 ml of 10% FCS-DMEM and
cultured at 37°C for 0–20 min in the presence of 20 µM
putrescine. Polyamines were measured as described
previously.10)
Statistical analysis  Results were compared by Student’s t
test and a P value of 0.05 or less was regarded as signifi-
cant. 
RESULTS
Effects of DFMO and putrescine on membrane fluidity,
adhesion and invasiveness of LC-AH cells   We found
previously that the maximal  DFMO-induced decreases in
the putrescine level (36% of the control) and invasiveness
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(62% of the control) of LC-AH cells were observed when
the cells had been pretreated with 0.5 mM DFMO for 5 h
and then co-cultured with a CPAE cell monolayer for 24 h
(migration period) in the absence of DFMO.  These de-
creases were completely reversed by 20 µM putrescine
added to the culture medium during pretreatment or the
migration period.10)  We also showed that methylthioade-
nosine and its analogues suppressed the invasiveness of
LC-AH cells and that this suppression was associated with
reductions of both methylation of tumor membrane phos-
pholipids and tumor membrane fluidity, measured by a
steady-state fluorescence polarization method.20)
The process of in vitro invasion of LC-AH cells through
a CPAE cell layer consists of two steps, adhesion of the tu-
mor cells to the cell layer and their migration through it.
Neither DFMO nor exogenous putrescine alone affected the
membrane fluidity or the adhesiveness of LC-AH cells (Ta-
ble I).  Under the experimental conditions employed, about
35% of the inoculated cells adhered to a CPAE cell layer
within 30 min after their inoculation, and this value in-
creased to a maximum of 46% within 2 h after cell inocula-
tion.  No further increase was observed by 6 h after cell
inoculation (data not shown).  But this maximal ratio (46%)
of adherent cells increased when a smaller number of LC-
AH cells was inoculated onto the same-sized CPAE cell
monolayer (unpublished data), suggesting a limited number
of binding sites in the CPAE cell layer for tumor cells.  In
control (DFMO-untreated) and putrescine-treated cells
which showed high putrescine levels,10) all these adherent
cells migrated through the CPAE cell layer (migratory
cells) during the migration period.  In DFMO-treated cells,
however, 39% (0.5 h co-cultured cells) and 36% (2 h co-
cultured cells) of the adhered cells did not migrate (nonmi-
gratory cells), but remained adhering to the CPAE cell layer
after 24 h incubation (Table I).  These nonmigratory cells
showed no migration even 30 h after inoculation.  Addition
of 20 µM putrescine to the medium during the migration
period restored cell invasiveness and all of the nonmigra-
t ry cells began to penetrate the CPAE cell layer (Table I).
Thus, DFMO treatment induced nonmigratory cells, which
were transformed to migratory cells in the presence of pu-
trescine.
As shown in Fig. 1, there were marked morphological
and cytochemical differences between nonmigratory and
migratory cells: the former were round with a low [Ca2+]i
(1.5–1.7×10−7 M), while the latter had a cauliflower-like
shape with a higher [Ca2+]i (2.2–3.1×10−7 M).  The [Ca2+]i
of all the cells that had penetrated the CPAE cell layer
(penetrating cells) was again low (1.6–2.0×1 –7 M).  Simul-
taneous observations of fluorescence intensity and mor-
phology of single control (DFMO-untreated) LC-AH cells
with an ACAS interactive laser cytometer showed that an
increase in [Ca2+]i was apparent 10 min after cell addition
and this increase preceded morphological transformation of
round cells to a cauliflower-like shape, which began about
30 min after cell addition (data not shown).  Control LC-
AH cells also adhered to a glass or plastic surface, but in
these cases, showed neither increase in [Ca2+]i nor cauli-
flower-like transformation (data not shown).
Effects of polyamines on [Ca2+]i and putrescine levels in
DFMO-treated LC-AH cells   The above findings sug-
gested a relationship between invasiveness and the [Ca2+]i








(cells/well) × 10–4 % (cells/well) × 10–4 %
None (control) 0.174±0.002 0.5 3.5±0.5 100 3.6±0.6 100
Put. (20 µM) 0.172±0.003 0.5 3.7±0.4 106 3.5±0.7 97
DFMO (0.5 mM) 0.170±0.002 0.5 3.4±0.4 97 2.2±0.5b) 61
DFMO + Put. 0.173±0.003 0.5 3.5±0.3 100 3.4±0.3c) 94
None (control) 2 4.6±0.7 100 4.5±0.5 100
Put. (20 µM) 2 4.5±0.7 98 4.6±0.7 102
DFMO (0.5 mM) 2 4.7±0.8 102 2.9±0.2b) 64
DFMO + Put. 2 4.4±0.3 96 4.6±0.6c) 102
LC-AH cells (1×106 cells/ml of 10% FCS-DMEM) were treated with 0.5 mM DFMO and 20 µM putrescine (Put.) for 5 h,
and then washed with PBS or 10% FCS-DMEM to remove the drugs. Fluorescence polarization was calculated from the
fluorescence intensity of PBS-washed cells as described in “Materials and Methods.” The cells (1×105 cells) washed with
10% FCS-DMEM were suspended in 4 ml of the same medium and co-cultured for 0.5 or 2 h with CPAE cell layers
grown on 60 mm dishes. Then cell adhesiveness and invasiveness were determined as described in “Materials and
Methods.”
a) Values are means±SD’s for 4 separatem experiments.
b) Significantly different from the control value.
c) Putrescine was added during the migration period.
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of the cells.  Therefore, we examined changes in the [Ca2+]i
of DFMO-induced nonmigratory LC-AH cells after addi-
tions of polyamines. Fig. 2 shows that on addition of pu-
trescine, the [Ca2+]i of nonmigratory cells was increased to
the same level as in migratory cells within 10 min, with
complete recovery of their invasiveness (Table I).  How-
ever, addition of spermidine or spermine did not increase
the [Ca2+]i or the invasiveness of the cells.
10)  Putrescine did
not cause a further increase in the high [Ca2+]i of migratory
cells that had not been treated with DFMO (data not
shown).  Moreover, 1,3-diaminopropane and 1,5-diamino-
pentane (cadaverine) did not cause significant recovery of
either the Ca2+ level or invasiveness of DFMO-treated non-
migratory cells (data not shown).
We could not measure the putrescine levels of DFMO-
treated migratory cells after addition of putrescine because
the adhered migratory cells were not easily detached from
the CPAE cell layer.  When DFMO-treated LC-AH cells
were cultured at 37°C without the CPAE cell layer and
polyamine levels were followed after addition of putrescine
by the method described in “Materials and Methods,” the
putrescine levels (nmol/µg DNA, average values of two ex-
periments) were 21.3 (0 min), 43.8 (5 min), 64.3 (10 min),
and 80.1 (20 min), indicating that the level 10 min after ad-
dition of putrescine was almost the same as that of DFMO-
untreated cells (70.5 nmol/µg DNA).  No changes in sper-
midine and spermine levels were observed.  These results
suggested that uptake of exogenous putrescine was associ-
ated with increase of [Ca2+]i in DFMO + putrescine-treated
migratory cells.
Effects of Ca2+ channel modulators on the invasiveness
and [Ca2+]i of LC-AH cells  Next we tested the effects of
various drugs that modulate cytosolic Ca2+ homeostasis on
the invasiveness of the tumor cells.  The drugs tested were
Ca2+ ionophores (ionomycin and A23187), antagonists
(verapamil, nifedipine and diltiazem) of the voltage-gated
Ca2+ channel, a blocker (ryanodine) of cyclic ADP-ribose-
triggered Ca2+ release from the endoplasmic reticulum,23)
and an inhibitor (thapsigargin) of endoplasmic reticulum
Ca2+-ATPase.24)  These drugs were added to the culture me-
dium during the migration period. Fig. 3 shows that none of
the calcium ionophores (10 µM) or antagonists (20 µM) of
the voltage-gated Ca2+ channel affected the invasiveness of
control cells, the DFMO-dependent suppression of invasion
or the putrescine-dependent restoration of DFMO-induced
suppression of the invasion. These calcium channel antago-
nists were reported to be effective in various tumor cells at
concentrations of less than  20 µM.25–29)  On the other hand,
ryanodine and thapsigargin, which modulate Ca2+ release in
the endoplasmic reticulum, had definite influences on the
invasiveness.  Ryanodine concentration-dependently low-
Fig. 1. Morphology (A) and [Ca2+]i (B) of LC-AH cells that ad-
hered to and penetrated a CPAE cell layer.  For A, DFMO-treated
(a) and control DFMO-untreated (b and c) LC-AH cells were cul-
tured on CPAE cell layers for 2 (b) or 24 (a and c) h.  The mor-
phologies of cells that adhered to (a and b) and penetrated (c) a
CPAE cell layer were observed by scanning electron (a and b) and
light (c) microscopes as described in “Materials and Methods.”
For B, indo 1-AM was loaded at 0 h (b) or at 24 h (a and c).  Col-
umns and bars show means and SD’s, respectively, of results in 3
separate experiments.  a, a DFMO-treated nonmigratory cell at 24
h;  b, a control migratory cell at 2 h;  c, a control penetrated cell at
24 h. Scale bar, 10 µm. ∗ Significant difference from (a).
Fig. 2. Effects of polyamines on [Ca2+]i in DFMO-treated nonmi-
gratory cells.  DFMO-treated cells were loaded with indo 1-AM as
described in “Materials and Methods” and co-cultured on CPAE cell
layers for 2 h.  The [Ca2+]i of nonmigratory cells that adhered to the
CPAE cell layer was followed after no addition (a), or addition (at
the arrow) of 20 µM putrescine (b), spermidine (c) or spermine (d).
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ered the invasiveness of control cells and cells treated with
DFMO with or without putrescine (Figs. 3 and 4A).  Ryan-
odine almost completely counteracted the effects of pu-
trescine on [Ca2+]i (Fig. 4B) and the invasiveness of the
cells (Fig. 4A), and the ryanodine-treated nonmigratory
cells also had a low [Ca2+]i (data not shown).  In other
words, the [Ca2+]i remained low in all the nonmigratory
cells induced by either DFMO or ryanodine.  In contrast,
thapsigargin alone dose-dependently enhanced the inva-
siveness of DFMO-treated cells (Fig. 4C) with elevation of
their [Ca2+]i in the absence of putrescine (Fig. 4D).  But
thapsigargin alone had no effect on the invasiveness of con-
trol cells (Fig. 3A).  These effects of thapsigargin were sim-
ilar to those of putrescine.  Ionomycin had no effect on the
invasiveness (Fig. 3), but increased the [Ca2+]i. Fig. 5
shows the surge of increase in [Ca2+]i in a DFMO-induced
nonmigratory cell after addition of ionomycin to the me-
dium during the migration period.  This pattern of increase
in [Ca2+]i was markedly different from those induced by pu-
trescine and thapsigargin (Fig. 4D).  The maximal [Ca2+]i
1 min after addition of ionomycin was 3 times that 10 min
after addition of putrescine or thapsigargin, but the iono-
mycin-induced increase lasted for only 2 min whereas the
putrescine- and thapsigargin-induced increase persisted for
at least the 10 min measurement period (Figs. 2, 4 and 5).
These results suggest that a prolonged increase in [Ca2+]i is
necessary for restoration of invasiveness after DFMO treat-
ment.  Nifedipine did not suppress the putrescine-evoked
increase in [Ca2+]i in nonmigratory cells (Fig. 5).
DISCUSSION
The present studies by ACAS laser cytometry and mi-
croscopy showed that all control LC-AH cells that adhered
to a CPAE cell layer showed an increase in [Ca2+]i, fol-
lowed by change from a round to a cauliflower-like shape
(Fig. 1), and then migration through the CPAE cell layer.
After penetration through the CPAE cell layer, the cells
again had a low [Ca2+]i (Fig. 1).  We found no transformed
cells (migratory cells) with a low [Ca2+]i and no nonmigra-
tory cells or cells that had penetrated the cell layer with a
high [Ca2+]i at any time after cell inoculation.  These find-
ings suggest that migratory cells maintain a high [Ca2+]i
during their migration period and that this level returns to
the original low level after their invasion of the CPAE cell
layer.  In DFMO-induced nonmigratory cells, the [Ca2+]i
was rapidly elevated for a prolonged time to the level in
migratory cells by addition of putrescine, but not spermi-
dine or spermine (Fig. 2). This implies that a high intracel-
lular level of putrescine is necessary for the increase in
[Ca2+]i evoked by adhesion of the tumor cells to the CPAE
cell layer and is prerequisite for their invasion of the layer.
Fig. 3. Effects of Ca2+ channel modulators on the invasiveness of LC-AH cells.  LC-AH cells were incubated for 5 h in the absence (A)
or presence (B) of 0.5 mM DFMO or 0.5 mM DFMO plus 20 µM putrescine (C).  Then they were washed and their invasiveness was
determined in the absence or presence of 10 µM Ca2+ ionophores, 20 µM antagonists of the voltage-gated Ca2+ channel, 10 µM ryanodine
or 5 µM thapsigargin.  Columns and bars show means and SD’s, respectively, of results in 3 separate experiments. ∗ Significantly differ-
ent from the control value (none).
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This implication was supported by the findings that [Ca2+]i
and the invasiveness of the cells were concomitantly de-
creased and increased by ryanodine and thapsigargin, re-
spectively (Figs. 3 and 4).
The putrescine-dependent increase in [Ca2+]i in DFMO-
treated nonmigratory cells was probably due to release of
Ca2+ from the endoplasmic reticulum because this increase
was not affected by nifedipine (Fig. 5) which inhibits influx
of extracellular Ca2+ into the cells, but was completely
inhibited by ryanodine (Fig. 4B), a blocker of the Ca2+-
induced Ca2+-release system through the endoplasmic ryan-
odine receptor.23)  The possibility of participation of putre-
scine-dependent Ca2+ release from the endoplasmic reticu-
lum in induction of invasiveness was supported by the
putrescine-like effects of thapsigargin (Figs. 3 and 4),
which is thought to restore the invasiveness of nonmigra-
tory cells due to increase in their [Ca2+]i by decrease in
influx of cytoplasmic Ca2+ into the endoplasmic reticulum
through the inhibition of endoplasmic Ca2+-ATPase.24)
There are reports that cyclic ADP-ribose is a natural ago-
nist of the ryanodine channel in a variety of animal cells30–35)
and that this channel is independently regulated by other
endoplasmic reticulum-located Ca2+-releasing systems that
are triggered by inositol 1,4,5-trisphosphate,33–35) and nico-
tinate adenine dinucleotide phosphate.36–38) The complete
inhibitions by ryanodine of putrescine-dependent recover-
ies of the [Ca2+]i and invasiveness of nonmigratory cells sug-
gest that putrescine is involved in either the increase in the
cellular level of cyclic ADP-ribose which is initiated by the
adhesion of LC-AH cells to a CPAE cell layer or the func-
tional expression of this cyclic nucleotide. Bourguignon et
al.39) reported that binding of the ryanodine receptor to
ankyrin, a cytoskeleton protein, evoked cyclic ADP-ribose-
induced Ca2+ release from internal vesicles of T-lymphoma
Fig. 4. Effects of ryanodine (A and B) and thapsigargin (C and D) on the invasiveness and [Ca2+]i of LC-AH cells.  The invasiveness (A
and C) of control (open circles) and DFMO-treated cells was determined in the absence (closed circles) or presence (closed triangles) of
20 µM putrescine and the indicated concentrations of ryanodine (A) or thapsigargin (C).  Points indicate mean values in 3–5 separate ex-
periments.  SD’s were all less than 11% of the means. ∗ Significantly different from the control (no addition).  In experiments on [Ca2+]i
(B and D), DFMO-treated and indo 1-AM-loaded LC-AH cells were co-cultured with CPAE cell layers for 2 h.  The [Ca2+]i of nonmigra-
tory cells was monitored after additions (at the arrow) of 20 µM putrescine (B and D), 10 µM ryanodine (B) or 5 µM thapsigargin (D).
Logarithmic scales are used for the abscissas (drug concentrations) in A and C.
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cells.  In connection with the functional expression, Chini
et al.40) reported that cyclic ADP-ribose-induced Ca2+
release in a homogenate of sea urchin eggs was strongly
inhibited by spermine, but not putrescine.  There are also
reports that among natural polyamines, spermine is the
most effective in modulating voltage-activated,41–43) N-
methyl-D-aspartate-mediated44) and inositol trisphosphate-
stimulated45) Ca2+ channels, while putrescine has little or no
effect.  But these in vitro effects of spermine and spermi-
dine observed at high concentrations (mM range) without
depletion by specific inhibitors may be explained by their
polybasic natures, resulting in their high affinities to nega-
tively charged cellular structures such as biomembranes
and nucleic acids and low-molecular-weight metabolites.
With regard to the latter, Mernissi-Arifi et al.46) reported the
formation of stable complexes of spermine and spermidine
with inositol trisphosphate.  Moreover, there are reports
that the cellular spermine level does not change appreciably
under a variety of physiological conditions1, 16, 17) in which
the putrescine level is markedly elevated.  Therefore, the
relationship between the observed effects of high concen-
trations of spermine in vitro and their physiological regula-
tory functions in vivo must be considered with caution.1)
Recently, Khan et al.47) reported that KCl depolarization-
induced serotonin release from fish brain synaptosomes is
mediated by KCl-stimulated influx of Ca2+ into the synap-
tosomes from the extracellular medium and that DFMO-
pretreatment resulted in decreases of both Ca2+ influx and
serotonin release which were restored by putrescine, the
tissue content of which is higher than those of spermidine
and spermine in various parts of fish brain.  Shinki et al.48)
reported that in vitamin D-deficient chick small intestine,
treatment with calcitriol resulted in marked elevation of the
putrescine level, mainly due to back-conversion of spermi-
dine,17) and stimulation of Ca2+ absorption that is thought to
be accompanied by enhanced Ca2+ passage across both mu-
cous and serous membranes of the epithelial cells.  Lower-
ing of the putrescine level by inhibitors of polyamine
oxidase and ornithine decarboxylase decreased Ca2+ ab-
sorption.  These and the present results support the idea
that putrescine is a cofactor for the Ca2+ current through
second messenger-stimulated or voltage-gated Ca2+ chan-
nels present in either the endoplasmic reticulum or plasma
membrane in putrescine-rich cells.
The function of the putrescine-dependent increase in
[Ca2+]i is unknown. Possibly this multifunctional messenger
participates in at least cell migration and morphological
transformation of tumor cells and their secretion or exocy-
tosis of factors that stimulate their invasiveness, because
these cellular events are thought to be accompanied by re-
arrangement of the actin-based cytoskeleton regulated by
actin-binding proteins that are modulated by changes in
[Ca2+]i.
49–51) For example, with regard to the relationship be-
tween polyamines and cell migration, McCormack et
al.52, 53) found that DFMO treatment reduced the migration
of small intestinal crypt cells concomitantly with decreases
in their actin stress fibers and lamellipodia due to redistri-
bution of F-actin and tropomyosin from stress fibers to the
actin cortex, and that their reduced migration was com-
pletely restored by exogenous polyamines, putrescine being
the essential polyamine for their migration.  Because the
endothelial cell layer, basement membrane and extracellu-
lar matrix are barriers against tumor cell invasion, tumor
cells produce and secrete factors that weaken or remove
these barriers.  These factors include an endothelial cell re-
traction factor54) and a matrix metalloproteinase-2 whose
transcription in human cancer cells is enhanced by recep-
tor-operated Ca2+ influx.55)
In summary, we have demonstrated a novel function of
putrescine in Ca2+ release from the ryanodine channel.  The
precise mechanism of this action of putrescine is unknown,
but the findings that 1,3-diaminopropane and 1,5-diamino-
pentane had scarcely any effect and the demonstration of an
arly response (within 2 min, Figs. 2, 4 and 5) of [Ca2+]i to
putrescine imply that putrescine interacts with a specific
site on the cyclic ADP-ribose binding receptor. 
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Fig. 5. Effects of ionomycin and nifedipine on [Ca2+]i of LC-AH
cells.  DFMO-treated and indo 1-AM-loaded LC-AH cells were
cultured on CPAE cell layers for 2 h.  The [Ca2+]i of nonmigratory
cells was followed after no addition (a), or addition (at the arrow)
of 10 µM ionomycin (b), 20 µM putrescine (c) or 20 µM pu-
trescine plus 20 µM nifedipine (d).
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